ARCHIVES

Scientists, Industry Identify Barriers To Development of Molecular Therapies

This article is from The Cancer Letter archive.

Vol. 28 No. 15 | April 12, 2002

Download PDF Visit The Full Archive

Related Articles

Erbitux Plus Radiation, Chemo, Appears To Provide CRs In A Small Phase II Study

February 23, 2007

Conferess Ok $10.9 Bil. NIH Bidget, OAM to Get $3.5 Million

October 15, 1993

HCFA Firm Against Reimbursement For Patients In Clinical Trials, Lasagna Committee Hears

March 24, 1989

STAR completes enrollment.

July 30, 2004

Interview with Christine Berg: ST Findings Relevant Only To High-Risk;

November 26, 2010

Capitol Hill: Senate bill would allow sale of therapies for catastrophic illness after phase I trials.

December 2, 2005